Executive announcement: Ambassador Medical adds to its sales, marketing team

TriMed Staff | | Health Imaging | Artificial Intelligence
Refurbished ultrasound equipment provider Ambassador Medical, LLC, a GE Healthcare company located in Carmel, Ind., named a new sales manager and director of marketing and business development. Rob Hargis has been promoted to the role of sales manager.  Hargis has been with Ambassador for over three years and has held sales positions in various industries. Additionally, Chris Wright has taken the director of marketing and business development position.  Wright served as a sales representative and application specialist for Ambassador over the past two years. She is a registered medical sonographer in OB/GYN and spent almost 17 seventeen years in patient care before going into medical sales. 

TriMed Staff

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.